{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkOz7ouMLDA","lastupdate":"2022-12-23T00:00:00.000Z","update_date":"2022-12-23T00:00:00.000Z","lastModified":"Jan 5, 2025","active":1,"confidence_score":91,"confidence_score_reason":"markets, not claimed","urlname":"pangea-biomed","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$tkLJWIVBjn8kDlbnZ08oMkRTRlab7Loi27ioBP00RLJqs7BQqVa1Os","name":"Pangea Biomed","oneliner":"Pan-cancer Therapy Response Predictor","registrar":"515823839","website":"https://pangeabiomed.com/","careerspage":"https://pangeabiomed.com/company/#careers","founded_month":3,"founded_year":2018,"formernames":["Pangea Therapeutics"],"sociallinks":{"twitter":"https://twitter.com/PangeaBiomed","youtube":"https://www.youtube.com/channel/UC0tgNPLez863ZMHRGrs-HyQ","facebook":"","linkedin":"https://www.linkedin.com/company/71201409","instagram":""},"social":["https://www.linkedin.com/company/71201409","https://www.youtube.com/channel/UC0tgNPLez863ZMHRGrs-HyQ","https://twitter.com/PangeaBiomed"],"flattenedsociallinks":"https://www.linkedin.com/company/71201409|https://www.youtube.com/channel/UC0tgNPLez863ZMHRGrs-HyQ|https://twitter.com/PangeaBiomed","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":17,"patent":0,"raised":12000000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Pangea Biomed is the developer of ENLIGHT, an advanced pan-cancer, pan-therapy response predictor. By combining machine learning, artificial intelligence, and deep RNA analysis, the company is mapping tumor molecular signatures to dynamically and adaptively personalize cancer care.  Pangea's unsupervised machine-learning approach makes ENLIGHT scalable and effective during the drug development process, when no clinical data is yet available.\n\nPangea is also developing EnlightDP, a response prediction technology based on the analysis of digital H&E slide images using its proprietary RNA expression imputation platform.\n\nPangea aims to bring effective precision oncology to cancer patients, improve oncology drug development, and empower oncologists to treat patients with success. Pangea is backed by NFX, and validations of its technology have been published in leading journals, including Med, Cell, Science Advances, Cancer Cell, and Nature Communications.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97235441755","country":null,"address":{"israeli":[{"id":"145fa9b8-acdd-46b6-8262-56fdd05ce0da","city":"Tel Aviv-Yafo","type":null,"address":"HaBarzel St 2a, Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"69Xpxqsbooo3T7XRff5ksio3R850tHbMgsEothP5l4ZK3bHghpmgx7","date":"Dec 15, 2022","link":"https://www.biopharmadive.com/press-release/20221215-pangea-biomed-adds-5m-in-additional-funding-for-its-multi-cancer-response/","source":"www.biopharmadive.com","visible":1,"analysis":{"tags":"biotech, precision oncology","company":"Pangea Biomed","layoffs":null,"summary":"Pangea Biomed, a biotech company, has announced $5M in additional funding, bringing its total seed round to $12M. The funding will be used to expand US operations, drive commercial partnerships, and scale product offerings. Pangea aims to improve precision oncology treatments and increase patient benefits by 5x through its ENLIGHT platform, which combines RNA sequencing with machine learning. The company has begun two clinical trials, published three papers, and established partnerships with pharmaceutical companies. Pangea plans to hire a Chief Business Officer to expand its work in the US. The funding comes after two peer-reviewed publications showcasing the success of Pangeas ENLIGHT platform. Pangea Biomed was founded in 2018 and is backed by NFX.","partners":null,"customers":null,"investors":"Danny Tocatly, NFX","confidence":9,"key_topics":["Funding","ENLIGHT platform","Precision oncology","Clinical trials","Partnerships"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5M","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"aXfJtG6trpcfOqL8zj6rS2a5FFdzbVN48u49c9UrXARIFqEcERxrSR","news_summary":"Pangea Biomed Adds $5M in Additional Funding for its Multi-Cancer Response Predictor Technology | BioPharma Dive","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"suBzeesgjSVbxcTdLyohW8NanbyypFKEiC56z8a4ULboxOaJfDaWj5","date":"Oct 15, 2022","link":"https://www.precisiononcologynews.com/business-news/pangea-biomed-nets-additional-5m-seed-funds#.Y5762H1ByUk","source":"www.precisiononcologynews.com","visible":1,"analysis":{"tags":["biotech","precision oncology","transcriptomics","machine-learning","funding"],"company":"Pangea Biomed","layoffs":null,"summary":"Pangea Biomed, a biotech startup, has raised an additional $5 million in seed funding. The company plans to use its transcriptomics-based machine-learning platform to expand precision oncology treatment opportunities for more cancer patients. Pangea aims to increase the number of patients benefiting from precision oncology treatments by fivefold. The company has already formed partnerships with pharmaceutical companies and is working with Massachusetts General Hospital and Sheba Hospital. The funds will be used to expand US-based activities, establish research partnerships, and hire a chief business officer. Pangeas goal is to improve oncology drug development and make personalized care accessible to all patients.","partners":["Massachusetts General Hospital","Sheba Hospital"],"customers":null,"investors":["Danny Tocatly","NFX"],"confidence":9,"key_topics":["biotech","precision oncology","transcriptomics","machine-learning","funding"],"date_of_event":"Thursday","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uwfETPp71t3dXiFVu8kibX6qqltHawMK62vcCBmPDDHQP56vGZLcGk","news_summary":"Pangea Biomed Nets Additional $5M in Seed Funds","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7b15d869-773c-482b-9eab-05669029b614","date":"Apr 7, 2022","link":"https://www.builtwithbiology.com/read/pangea-biomed-launches-with-worlds-most-advanced-multi-cancer-response-predictor-increasing-patient-benefits-from-precision-oncology-by-5x","source":"www.builtwithbiology.com","visible":1,"analysis":{"tags":["precision oncology","gene social graph"],"company":"Pangea Biomed","layoffs":null,"summary":"Pangea Biomed, a precision oncology biotech company, has developed the worlds most advanced multi-cancer response predictor, ENLIGHT. The company has raised $7M in seed funding led by NFX to support research and development, partnerships, and clinical trials. Pangea aims to increase the number of patients benefiting from precision oncology treatments by using a gene social graph and RNA sequencing to match patients with the right drugs. The companys technology has been validated through a retrospective analysis of over 1,000 patients. Pangea is collaborating with the National Cancer Institute and Sheba Hospital, among others, and is backed by NFX. The companys research has been published in top scientific journals.","partners":["National Cancer Institute","Sheba Hospital"],"customers":null,"investors":"NFX","confidence":9,"key_topics":["precision oncology","gene social graph","RNA sequencing","ENLIGHT platform","seed funding"],"date_of_event":"2022-04-07","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$7M","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"RxefGh5V7a9O5zF1iGz1aSPiFrtP4GZTYKz5Atw2YMxcsHjqsCvXMy","news_summary":"Pangea Biomed Launches with World's Most Advanced Multi-Cancer Response Predictor, Increasing Patient Benefits from Precision Oncology by 5x - SynBioBeta","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":3,"techcommunityinvolvement":null,"mediagallery":[{"id":"uM9zdfK1vbXqJ1gToWmWut7QYJWxjntIEBXUigmCEugoJ4rSxPVhzJ","timestamp":"2023-02-09 10:54:13.000000","resources_type":2,"resources_title":"Redefining Precision Oncology Through Computational Transciptomics","resources_file_name":"2VEdCAHBvBE","alt":"Redefining Precision Oncology Through Computational Transciptomics logo","imageurl":"https://img.youtube.com/vi/2VEdCAHBvBE/0.jpg","url":"http://youtu.be/2VEdCAHBvBE"}],"tags":["actionable-insights","biotechnology","precision-medicine","treatments","oncology","artificial-intelligence","targeted-therapy","pharma-companies","digital-healthcare","decision-support","machine-learning","immunotherapy","cancer","drug-discovery","laboratories","personalization","clinical-trials"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["ENLIGHT"],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$5M","totalrounds":2,"fundingstage":"Seed","totalfunding":"$12M","publicinvestors":2,"lastpublicfunding":5000000,"totalpublicrounds":2,"totalpublicfunding":12000000},"team":[{"name":"Eyal  Schiff","email":"eyal.s@pangeabiomed.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkKztlv8IDA","bounced":true,"claimed":0,"founder":0,"urlname":"eyal-schiff-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQjK_QygoM","position":"Chairman Of The Board","last_name":"Schiff","claimtoken":"kUWKdkQ8qlU3Fqom7nCtOcdV4Wp4lhl3ptpKSpfyMEdnjhY1VdHEYQ","first_name":"Eyal ","picturekey":"$1if449N08jj7jlDeOmFFkEIIGHKrNcnbkI5e0k54IioSeSSm4Q05hD.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eyal-schiff-b54545203/","unsubscribed":true,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-23 09:29:42.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$1if449N08jj7jlDeOmFFkEIIGHKrNcnbkI5e0k54IioSeSSm4Q05hD.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Tuvik  Beker","email":"tuvik@pangeabiomed.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkKz3voMJDA","bounced":false,"claimed":0,"founder":0,"urlname":"tuvik-beker","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQrMGe1QsM","position":"CEO & Board Member","last_name":"Beker","claimtoken":"SWsbdfzM68tD4qDf1wMcJcihDtfxFNv14WpEodBYlGW5P1ZV3rEkis","first_name":"Tuvik ","picturekey":"$Dvv10DNgVsiPhdBHmPo3Ig8BJzB9f6qBkqHJIjrCDg83Q1CU2ojCax.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tuvik-beker-767110/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-19 15:52:19.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$Dvv10DNgVsiPhdBHmPo3Ig8BJzB9f6qBkqHJIjrCDg83Q1CU2ojCax.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Zeev  Ronai","email":"zeev@pangeabiomed.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkJzIn90IDA","bounced":true,"claimed":0,"founder":1,"urlname":"zeev-ronai","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ7MXwmQoM","position":"Co-founder","last_name":"Ronai","claimtoken":"59c0494e5fb4bab5dfa66ac813534568af898ffea55e206a17bbd9b677c5e4cc","first_name":"Zeev ","picturekey":"$zJPW4hVXnGI5DKwztZh4W5Jy5Z9BxSYDZ2KvAgX79R97XylsxgESsm.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ze-ev-ronai-38271a7/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$zJPW4hVXnGI5DKwztZh4W5Jy5Z9BxSYDZ2KvAgX79R97XylsxgESsm.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Eyal  Gottlieb","email":"eyal@pangeabiomed.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkKztlr8LDA","bounced":false,"claimed":0,"founder":1,"urlname":"eyal-gottlieb","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ7OXlmQoM","position":"Co-founder","last_name":"Gottlieb","claimtoken":"XL6Ac95uAx6rwecYvioQwXU9UWqTmf6I2ePXz2AhfJwwpEG3MDS3fi","first_name":"Eyal ","picturekey":"$YH2kMTL4tMEEls7dVjcYsWF11c7XBAi0kAqA1Bm3aBykvgsVpEg9y4.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eyal-gottlieb-b8aa10/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-23 09:29:23.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$YH2kMTL4tMEEls7dVjcYsWF11c7XBAi0kAqA1Bm3aBykvgsVpEg9y4.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Eytan  Ruppin","email":"eytan@pangeabiomed.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkOyHs8gLDA","bounced":true,"claimed":0,"founder":1,"urlname":"eytan-ruppin-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQrNyjuggM","position":"Co-founder","last_name":"Ruppin","claimtoken":"7rrOZUYblqs4EMBqcTZvuILjozklo93Lm4Gk7HHaSkjkM6UkiyuziL","first_name":"Eytan ","picturekey":"$wvr1GAbWn0Jy9stzyGxZjAusZyIjCqSccHrJKXp3wYVP9PlWEa2P7k.jpeg","claimeddate":null,"linkedinurl":null,"unsubscribed":true,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-23 09:29:49.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$wvr1GAbWn0Jy9stzyGxZjAusZyIjCqSccHrJKXp3wYVP9PlWEa2P7k.jpeg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Emmanuel Elalouf","email":"emmanuel@pangeabiomed.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkKz3voMKDA","bounced":false,"claimed":0,"founder":0,"urlname":"emmanuel-elalouf","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQrOjD1QsM","position":"COO","last_name":"Elalouf","claimtoken":"aRnxpuxS6sRkYV3OV5JqMzZ89wYt3GYXhFfvwf7T6O6qNxKF8DoJaa","first_name":"Emmanuel","picturekey":"$Iwx9BAuMrMKJsEZqUlUWywnchsdaiTdnzx7ZEIEh8HN0II3jkAvwSd.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/emmanuel-elalouf-1913773/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-23 09:29:46.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$Iwx9BAuMrMKJsEZqUlUWywnchsdaiTdnzx7ZEIEh8HN0II3jkAvwSd.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ranit  Aharonov","email":"ranit@pangeabiomed.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkIy5mOoJDA","bounced":false,"claimed":0,"founder":0,"urlname":"ranit-aharonov","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQzLqRyAkM","position":"CTO","last_name":"Aharonov","claimtoken":"nCeAvXmT2FLtK5QOr9HM7wooIniMdoYHvzgFxiUADrlFrT6KfX7pPN","first_name":"Ranit ","picturekey":"$vWpmoYcYTaEjncAabSC4GrEeoBNu9RzTyvsxBwRBTMwokW2giGha6l.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ranit-aharonov-a1b4231/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-23 09:29:56.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$vWpmoYcYTaEjncAabSC4GrEeoBNu9RzTyvsxBwRBTMwokW2giGha6l.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Morris Rieger","email":"morris@pangeabiomed.com","phone":"","gender":"Male","userid":"0CCOqpVFQgvqStyMEmkK9DIPH3hehkExEJfM2OJMuEteN7vokse5FT","bounced":false,"claimed":1,"founder":0,"urlname":"morris-rieger","visible":1,"memberid":"BGYBLsELgI7p8S68kZjiviiUS1ozSknIauDwEK5y2ZQ02ixdP6SvJD","position":"Business Development Analyst","last_name":"Rieger","claimtoken":"ibGwIJXfUDBeqzFh92vUuARKgFVqV8GyeCRoWcWGng4Ps8bGQ81WyM","first_name":"Morris","picturekey":null,"claimeddate":"2023-02-08","linkedinurl":"https://www.linkedin.com/in/morrisrieger/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-02-08 17:48:00.000000","initials":"MR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2022-04-13T00:00:00.000Z","crunchbaseid":"pangea-biomed","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2022-04-13T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"y8iQpRGGholuGK0D9qS9i1zW9cZpAPC7enffgmyL0k8OLTrrVdc3fW","date":"Dec 2022","amount":"$5M","source":"https://www.biopharmadive.com/press-release/20221215-pangea-biomed-adds-5m-in-additional-funding-for-its-multi-cancer-response/ ' https://www.precisiononcologynews.com/business-news/pangea-biomed-nets-additional-5m-seed-funds#.Y5762H1ByUk","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"XMGXO3xpGg5MnNHn6tKbBQvcqrv690M7uOgcuBxAjdbDDNu1omJdHM","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "},{"name":"Danny Tocatly","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/danny-tocatly-1","logokey":null,"tagline":"","urlname":"/investor_page/danny-tocatly-1","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEu9TPCQw","fundingtype":"Angel","leadpartner":null,"investmentid":"gAJkH0ZIGdiDFoUmKXiNi0j3EUNKGsNawLxaM2E5ZT07hETeuGWg4p","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCs7cLuCAw","date":"Apr 2022","amount":"$7M","source":"https://www.builtwithbiology.com/read/pangea-biomed-launches-with-worlds-most-advanced-multi-cancer-response-predictor-increasing-patient-benefits-from-precision-oncology-by-5x","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"a847eabc-6e02-4569-afdb-92ae0f6492a5","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"3/2018","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Pangea Biomed","logourl":"https://storage.googleapis.com/clean-finder-353810/$tkLJWIVBjn8kDlbnZ08oMkRTRlab7Loi27ioBP00RLJqs7BQqVa1Os","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$tkLJWIVBjn8kDlbnZ08oMkRTRlab7Loi27ioBP00RLJqs7BQqVa1Os","seoabout":"Pangea Biomed is the developer of ENLIGHT, an advanced pan-cancer, pan-therapy response predictor. By combining machine learning, artificial intelligence, ...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":8,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Medical Decision Support","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Medical Decision Support"}]},{"title":"Pharma & Medical Biotechnology","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Laboratories","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Laboratories"},{"title":"Providers","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]},{"title":"Life Sciences","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"},{"title":"Biotechnology","key":"0-0-1-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Machine Learning","key":"0-0-0","path":"TechnologyClassificationModel>Artificial Intelligence>Machine Learning"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Medical Decision Support","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Artificial Intelligence","Machine Learning"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Laboratories","Providers","Life Sciences","Pharmaceuticals","Biotechnology"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"y8iQpRGGholuGK0D9qS9i1zW9cZpAPC7enffgmyL0k8OLTrrVdc3fW","date":"Dec 2022","amount":"$5M","source":"https://www.biopharmadive.com/press-release/20221215-pangea-biomed-adds-5m-in-additional-funding-for-its-multi-cancer-response/ ' https://www.precisiononcologynews.com/business-news/pangea-biomed-nets-additional-5m-seed-funds#.Y5762H1ByUk","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"XMGXO3xpGg5MnNHn6tKbBQvcqrv690M7uOgcuBxAjdbDDNu1omJdHM","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "},{"name":"Danny Tocatly","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/danny-tocatly-1","logokey":null,"tagline":"","urlname":"/investor_page/danny-tocatly-1","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEu9TPCQw","fundingtype":"Angel","leadpartner":null,"investmentid":"gAJkH0ZIGdiDFoUmKXiNi0j3EUNKGsNawLxaM2E5ZT07hETeuGWg4p","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCs7cLuCAw","date":"Apr 2022","amount":"$7M","source":"https://www.builtwithbiology.com/read/pangea-biomed-launches-with-worlds-most-advanced-multi-cancer-response-predictor-increasing-patient-benefits-from-precision-oncology-by-5x","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"a847eabc-6e02-4569-afdb-92ae0f6492a5","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}